Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
Aulos Bioscience, Inc.
Aulos Bioscience, Inc.
H. Lee Moffitt Cancer Center and Research Institute
ImmunityBio, Inc.
Ocellaris Pharma, Inc.
University of Washington
Memorial Sloan Kettering Cancer Center
Melanoma and Skin Cancer Trials Limited
Fred Hutchinson Cancer Center
ImmunityBio, Inc.
Melanoma and Skin Cancer Trials Limited
ImmunityBio, Inc.
4SC AG
EMD Serono
Fate Therapeutics
Jules Bordet Institute
Kartos Therapeutics, Inc.
Fred Hutchinson Cancer Center
4SC AG
Merck KGaA, Darmstadt, Germany